For: | Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, Jiang ZH, Shang J, Zhang Y, Jiang Y, Zhang SD. Polymorphisms at cholesterol 7α-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 2004; 10(10): 1508-1512 [PMID: 15133863 DOI: 10.3748/wjg.v10.i10.1508] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/1508.htm |
Number | Citing Articles |
1 |
Malcolm A. Lyons, Henning Wittenburg. Cholesterol Gallstone Susceptibility Loci: A Mouse Map, Candidate Gene Evaluation, and Guide to Human LITH Genes. Gastroenterology 2006; 131(6): 1943 doi: 10.1053/j.gastro.2006.10.024
|
2 |
Lizhuo Li, Xin Qiao, Xia Wang, Di Liu, Qingmu Xue, Lu Han, Fei Dai, Guomin Ma, Zhipeng Yang, Tao Zhang, Shuo Yang, Shikang Cai, Mingyue Gao, Jingyun Yang. The association between apolipoprotein E and gallstone disease: an updated meta-analysis. BMC Medical Genetics 2019; 20(1) doi: 10.1186/s12881-019-0843-6
|
3 |
Kaori Nakamoto, Shuang Wang, Robert D Jenison, Grace L Guo, Curtis D Klaassen, Yu-Jui Yvonne Wan, Xiao-bo Zhong. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genetics 2006; 7(1) doi: 10.1186/1471-2156-7-29
|
4 |
Anvesha Srivastava, Sachchida Nand Pandey, Gourdas Choudhuri, Balraj Mittal. Role of genetic variant A-204C of cholesterol 7α-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Molecular Genetics and Metabolism 2008; 94(1): 83 doi: 10.1016/j.ymgme.2007.11.014
|
5 |
ANN W. HSING, ASIF RASHID, SUSAN S. DEVESA, JOSEPH F. FRAUMENI. Cancer Epidemiology and Prevention. 2006; : 787 doi: 10.1093/acprof:oso/9780195149616.003.0040
|
6 |
Wei Huang, Rishipal R. Bansode, Yan Xie, Leslie Rowland, Madhu Mehta, Nicholas O. Davidson, Kamal D. Mehta. Disruption of the Murine Protein Kinase Cβ Gene Promotes Gallstone Formation and Alters Biliary Lipid and Hepatic Cholesterol Metabolism. Journal of Biological Chemistry 2011; 286(26): 22795 doi: 10.1074/jbc.M111.250282
|
7 |
Faiza Qayyum, Bo K Lauridsen, Ruth Frikke-Schmidt, Klaus F Kofoed, Børge G Nordestgaard, Anne Tybjærg-Hansen. Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease. European Heart Journal 2018; 39(22): 2106 doi: 10.1093/eurheartj/ehy068
|
8 |
Tripty Chauhan, R.D. Mittal, B. Mittal. Evaluation of genetic association of 40 SNPs in candidate genes with cholesterol gallstone disease in north Indian population. Meta Gene 2019; 21: 100579 doi: 10.1016/j.mgene.2019.100579
|
9 |
I. N. Grigor’eva, T. E. Notova. Apolypoprotein E gene polymorphism, gallstone disease, diabetes 2 type and lipid metabolism disorders. Ateroscleroz 2023; 19(1): 47 doi: 10.52727/2078-256X-2023-19-1-47-56
|
10 |
Tiangang Li, Udayan Apte. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer. Advances in Pharmacology 2015; 74: 263 doi: 10.1016/bs.apha.2015.04.003
|
11 |
F. Lammert, T. Sauerbruch. Disease Progression and Disease Prevention in Hepatology and Gastroenterology. Falk Symposium 2006; 150: 53 doi: 10.1007/1-4020-5224-3_6
|
12 |
Mateusz Kurzawski, Zygmunt Juzyszyn, Andrzej Modrzejewski, Andrzej Pawlik, Marek Wiatr, Bogusław Czerny, Ryszard Adamcewicz, Marek Droździk. Apolipoprotein B (APOB) Gene Polymorphism in Patients with Gallbladder Disease. Archives of Medical Research 2007; 38(3): 360 doi: 10.1016/j.arcmed.2006.11.003
|
13 |
Mansi Shukla, Anil Kumar, Raj Kumar Srivastava, Shirin Jahan. Anatomical and molecular studies of cytochrome P450 family CYP7A1 gene polymorphism and its association with gallstone in north Indian population. Journal of the Anatomical Society of India 2018; 67(1): 6 doi: 10.1016/j.jasi.2018.05.006
|
14 |
Yoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki. Associations between Lifestyle-Related Diseases and Transporters Involved in Intestinal Absorption and Biliary Excretion of Cholesterol. Biological & Pharmaceutical Bulletin 2018; 41(1): 1 doi: 10.1248/bpb.b17-00690
|
15 |
F. Lammert, H. Wittenburg. Genetics in Liver Diseases. Falk Symposium 2007; 156: 12 doi: 10.1007/978-1-4020-6393-0_3
|
16 |
Frank Lammert, Tilman Sauerbruch. Mechanisms of Disease: the genetic epidemiology of gallbladder stones. Nature Clinical Practice Gastroenterology & Hepatology 2005; 2(9): 423 doi: 10.1038/ncpgasthep0257
|
17 |
Ho Jin Kim, Hyun-Young Park, Eunkyung Kim, Kwang-Soo Lee, Kwang-Kuk Kim, Byung-Ok Choi, Seung Min Kim, Joon Seol Bae, Soo Ok Lee, Ji Yong Chun, Tae Joon Park, Hyun Sub Cheong, Inho Jo, Hyoung Doo Shin. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiology of Disease 2010; 37(2): 349 doi: 10.1016/j.nbd.2009.10.013
|
18 |
Lingyu Fu, Yanyan Zhao, Xiaomei Wu, Hong Liu, Jingpu Shi, Jingyu Lu, Bo Zhou. CYP7A1 genotypes and haplotypes associated with hypertension in an obese Han Chinese population. Hypertension Research 2011; 34(6): 722 doi: 10.1038/hr.2011.18
|
19 |
Tripty Chauhan, R. D. Mittal, B. Mittal. Association of Common Single Nucleotide Polymorphisms of Candidate Genes with Gallstone Disease: A Meta-Analysis. Indian Journal of Clinical Biochemistry 2020; 35(3): 290 doi: 10.1007/s12291-019-00832-1
|
20 |
Olga Renner, Simone Harsch, Elke Schaeffeler, Stefan Winter, Matthias Schwab, Marcin Krawczyk, Jonas Rosendahl, Henning Wittenburg, Frank Lammert, Eduard F. Stange, Iris Schrijver. A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease. PLoS ONE 2009; 4(10): e7321 doi: 10.1371/journal.pone.0007321
|
21 |
Zhao-Yan Jiang, Qu Cai, Er-Zhen Chen, Haibin Wang. Association of Three Common Single Nucleotide Polymorphisms of ATP Binding Cassette G8 Gene with Gallstone Disease: A Meta-Analysis. PLoS ONE 2014; 9(1): e87200 doi: 10.1371/journal.pone.0087200
|
22 |
Frank Grünhage, Frank Lammert. Pathogenesis of gallstones: a genetic perspective. Best Practice & Research Clinical Gastroenterology 2006; 20(6): 997 doi: 10.1016/j.bpg.2006.05.007
|
23 |
Frank Lammert, Juan-Francisco Miquel. Gallstone disease: From genes to evidence-based therapy. Journal of Hepatology 2008; 48: S124 doi: 10.1016/j.jhep.2008.01.012
|
24 |
Zygmunt Juzyszyn, Mateusz Kurzawski, Agnieszka Lener, Andrzej Modrzejewski, Andrzej Pawlik, Marek Droździk. Cholesterol 7α-Hydrolase (CYP7A1) c.−278A>C Promoter Polymorphism in Gallstone Disease Patients. Genetic Testing 2008; 12(1): 97 doi: 10.1089/gte.2007.0067
|
25 |
M. Dixit, G. Choudhuri, B. Mittal. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Digestive and Liver Disease 2006; 38(6): 397 doi: 10.1016/j.dld.2006.02.005
|
26 |
Xiaoqiang Xiang, Janne T. Backman, Pertti J. Neuvonen, Mikko Niemi. Gender, but not CYP7A1 or SLCO1B1 Polymorphism, Affects the Fasting Plasma Concentrations of Bile Acids in Human Beings. Basic & Clinical Pharmacology & Toxicology 2012; 110(3): 245 doi: 10.1111/j.1742-7843.2011.00792.x
|
27 |
Q. Chen, W.J. Li, Y.Y. Wan, C.D. Yu, W.G. Li. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population. Genetics and Molecular Research 2012; 11(1): 548 doi: 10.4238/2012.March.8.3
|
28 |
Sobha Puppala, Gerald D. Dodd, Sharon Fowler, Rector Arya, Jennifer Schneider, Vidya S. Farook, Richard Granato, Thomas D. Dyer, Laura Almasy, Christopher P. Jenkinson, Andrew K. Diehl, Michael P. Stern, John Blangero, Ravindranath Duggirala. A Genomewide Search Finds Major Susceptibility Loci for Gallbladder Disease on Chromosome 1 in Mexican Americans. The American Journal of Human Genetics 2006; 78(3): 377 doi: 10.1086/500274
|
29 |
Dietmar M. Klass, Nadine Lauer, Birgit Hay, Wolfgang Kratzer, Michael Fuchs. Arg64Variant of the ß3-Adrenergic Receptor is Associated With Gallstone Formation. The American Journal of Gastroenterology 2007; 102(11): 2482 doi: 10.1111/j.1572-0241.2007.01430.x
|
30 |
Silvana Zanlungo, Attilio Rigotti. Determinants of transhepatic cholesterol flux and their relevance for gallstone formation. Liver International 2009; 29(3): 323 doi: 10.1111/j.1478-3231.2009.01972.x
|
31 |
Anvesha Srivastava, Gourdas Choudhuri, Balraj Mittal. CYP7A1 (−204 A>C; rs3808607 and −469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population. Metabolism 2010; 59(6): 767 doi: 10.1016/j.metabol.2009.09.021
|
32 |
Hongqun Yang, Lanlan Chen, Kaiyu Liu, Chengnan Li, Haitao Li, Kezhen Xiong, Zehan Li, Chuang Lu, Wei Chen, Yahui Liu. Mendelian randomization rules out the causal relationship between serum lipids and cholecystitis. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-01082-y
|
33 |
A.L.V. Barcelos, R. Chies, S.E.M. Almeida, M. Fiegenbaum, I.D. Schweigert, F.G.L. Chula, M.L. Rossetti, C.M.D. Silva. Association of CYP7A1 -278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients. Brazilian Journal of Medical and Biological Research 2009; 42(6): 487 doi: 10.1590/S0100-879X2009000600003
|
34 |
Tomasz Iwanicki, Anna Balcerzyk, Pawel Niemiec, Tomasz Nowak, Anna Ochalska-Tyka, Jolanta Krauze, Sylwia Kosiorz-Gorczynska, Wladyslaw Grzeszczak, Iwona Zak. CYP7A1Gene Polymorphism Located in the 5′ Upstream Region Modifies the Risk of Coronary Artery Disease. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/185969
|
35 |
Hanns-Ulrich Marschall, Despina Katsika, Mats Rudling, Curt Einarsson. The genetic background of gallstone formation: An update. Biochemical and Biophysical Research Communications 2010; 396(1): 58 doi: 10.1016/j.bbrc.2010.02.143
|
36 |
Aksana Höblinger, Frank Lammert. Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers. Current Opinion in Gastroenterology 2008; 24(3): 363 doi: 10.1097/MOG.0b013e3282f79b32
|
37 |
Qiang Cai, Zhen-Qiang Wang, Qu Cai, Chen Li, Er-Zhen Chen, Zhao-Yan Jiang. Relationship between CYP7A1 -204A > C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-126
|
38 |
Tetsurou Hirata, Mikihiro Fujioka, Kenji A. Takahashi, Yuji Arai, Takeshi Asano, Masashi Ishida, Masaaki Kuribayashi, Kiyokazu Akioka, Masahiko Okamoto, Norio Yoshimura, Yoshiko Satomi, Hoyoku Nishino, Wakaba Fukushima, Yoshio Hirota, Shigeo Nakajima, Shigeaki Kato, Toshikazu Kubo. ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. Journal of Orthopaedic Science 2007; 12(3): 199 doi: 10.1007/s00776-007-1110-9
|
39 |
Eda Sezer, Birsen Can Demirdöğen, Şeref Demirkaya, Giray Bulut, Merve Akkulak, Emre Evin, Orhan Adalı. Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population. Neurological Sciences 2022; 43(4): 2611 doi: 10.1007/s10072-021-05597-1
|
40 |
Lihong Zhang, Jingjing Tang, Yindi Wang, Xiang Wang, Fang Wang. Association of CYP7A1 and CYP2E1 Polymorphisms with Type 2 Diabetes in the Chinese Han Populations. Pharmacogenomics and Personalized Medicine 2022; : 843 doi: 10.2147/PGPM.S367806
|
41 |
Nevein M. Al-sheikh, Sally M. El-Hefnway, Ahlam A. El-Shetahy. Cholesterol 7- alpha hydroxylase gene ( CYP7A1 ) promoter polymorphism rs3808607 as a risk factor for pulmonary tuberculosis in Egypt. Meta Gene 2018; 16: 66 doi: 10.1016/j.mgene.2018.01.012
|
42 |
|
43 |
|
44 |
Frank Lammert, Franz‐Ludwig Dumoulin, Tilman Sauerbruch. Textbook of Hepatology. 2007; : 1518 doi: 10.1002/9780470691861.ch19c
|
45 |
Clemens Schafmayer, Jürgen Tepel, Andre Franke, Stephan Buch, Sören Lieb, Marcus Seeger, Frank Lammert, Bernd Kremer, Ulrich R. Fölsch, Fred Fändrich, Stefan Schreiber, Jochen Hampe. Investigation of the Lith1 candidate genes ABCB11 and LXRA in human gallstone disease. Hepatology 2006; 44(3): 650 doi: 10.1002/hep.21289
|
46 |
Krisztina Hagymási, Zsolt Tulassay. Genetic background of the multifactorial liver and bile duct diseases. Orvosi Hetilap 2007; 148(4): 147 doi: 10.1556/OH.2007.27987
|
47 |
Chenghao Zhang, Wanlin Dai, Shaojie Yang, Shuodong Wu, Jing Kong. Resistance to Cholesterol Gallstone Disease: Hepatic Cholesterol Metabolism. The Journal of Clinical Endocrinology & Metabolism 2024; 109(4): 912 doi: 10.1210/clinem/dgad528
|
48 |
Yi Gong, Leida Zhang, Ping Bie, Huaizhi Wang, Antonio Moschetta. Roles of ApoB-100 Gene Polymorphisms and the Risks of Gallstones and Gallbladder Cancer: A Meta-Analysis. PLoS ONE 2013; 8(4): e61456 doi: 10.1371/journal.pone.0061456
|
49 |
|
50 |
F. Lammert, T. Sauerbruch. Future Perspectives in Gastroenterology. 2008; : 99 doi: 10.1007/978-1-4020-8833-9_9
|
51 |
Ikuko Kato, Susan Land, Jill Barnholtz-Sloan, Richard K. Severson. APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease. Cholesterol 2011; 2011: 1 doi: 10.1155/2011/896360
|
52 |
Gregor Lorbek, Monika Lewinska, Damjana Rozman. Cytochrome P450s in the synthesis of cholesterol and bile acids – from mouse models to human diseases. The FEBS Journal 2012; 279(9): 1516 doi: 10.1111/j.1742-4658.2011.08432.x
|
53 |
Shih-Chang Chuang, Edward Hsi, King-Teh Lee. . Advances in Clinical Chemistry 2013; 60: 143 doi: 10.1016/B978-0-12-407681-5.00005-2
|